Table 2.
Summary of benefits and risks associated with mRNA COVID-19 vaccines booster dose
| Benefits | Risks * |
|---|---|
| Infection rate | Cardiac related complications such as myocarditis and pericarditis |
| Severity of Signs and Symptoms | Lung related complications such as pneumonitis and interstitial lung disease |
| Overall Hospitalization | Cutaneous adverse reactions such as hypersensitivity and psoriasis, including exacerbation of the symptoms |
| Intensive Care Unit (ICU) Hospitalization | Hematologic related such as thrombocytopenia |
| Death rate | Efficacy against new variants |
| Waning immunity over time |
* Adverse events/reactions are mostly short-term and differ according to certain demographics such as age, ethnicity, etc.